PRESS RELEASE published on 08/10/2026 at 15:59, 1 month 1 day ago Auddia Announces SEC Effectiveness of S-4 Registration Statement Clearing Major Merger Milestone Boulder, Colo., August 10th, 2026, FinanceWire
PRESS RELEASE published on 08/10/2026 at 15:56, 1 month 1 day ago Morgan State University Ranked Among Newsweek’s America’s Best Colleges for Women 2026 BALTIMORE, MD, August 10th, 2026, FinanceWire
PRESS RELEASE published on 08/10/2026 at 15:56, 1 month 1 day ago Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets, expanding international presence with new agreements for cold plasma technology Distribution Partnerships International Presence Viromed Medical AG Cold Plasma Technology ViroCAP®
PRESS RELEASE published on 08/10/2026 at 15:46, 1 month 1 day ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses 4.75% stake in Tate & Lyle plc through Form 8.3 filing. Details of relevant securities and positions provided The Vanguard Group, Inc. Form 8.3 Relevant Securities Stake Disclosure Tate & Lyle Plc
PRESS RELEASE published on 08/10/2026 at 15:44, 1 month 1 day ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.55% interest in Spire Healthcare Group plc's relevant securities. Dealings made on 07 August 2026 Securities Disclosure Vanguard Group Dealings Spire Healthcare Group
PRESS RELEASE published on 08/10/2026 at 15:43, 1 month 1 day ago Form 8.3 - The Vanguard Group, Inc.: Senior plc The Vanguard Group, Inc. discloses 5.23% stake in Senior plc as of 07 August 2026 as per Form 8.3 under Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure Senior Plc
PRESS RELEASE published on 08/10/2026 at 15:42, 1 month 1 day ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.65% stake in SEGRO plc. Additional disclosure for Prologis, Inc. No other dealings reported Disclosure Vanguard Group Stake SEGRO PLC Prologis Inc.
PRESS RELEASE published on 08/10/2026 at 15:41, 1 month 1 day ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.71% ownership in Schroders plc. Purchase of 25,009 and sale of 10,192 20p ordinary shares at 5.84 GBP per unit The Vanguard Group Schroders Plc Ownership Disclosure Purchase And Sale 20p Ordinary Shares
PRESS RELEASE published on 08/10/2026 at 15:39, 1 month 1 day ago Form 8.3 - The Vanguard Group, Inc.: Rotork plc The Vanguard Group, Inc. discloses a 5.44% ownership position in Rotork plc shares. Details on holdings and recent transactions provided The Vanguard Group Share Transactions Ownership Position Stock Holdings Rotork Plc
PRESS RELEASE published on 08/10/2026 at 15:38, 1 month 1 day ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc. The Vanguard Group, Inc. discloses 13.52% ownership of Prologis, Inc. securities in a Form 8.3 filing under Takeover Code. Additional interest in SEGRO plc noted Form 8.3 Takeover Code Vanguard Group SEGRO PLC Prologis Inc.
Published on 09/11/2026 at 17:00, 3 hours 32 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 3 hours 32 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 5 hours 7 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 5 hours 32 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 6 hours 2 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 19:44, 47 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 2 hours 17 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 2 hours 32 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 13 hours 32 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 13 hours 32 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 13 hours 32 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 13 hours 32 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
![Logo of [UNKNOWN]](https://logos.symex.be/img/.jpg)
